Advertisement

Topics

Companies Related to "Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer" [Most Relevant Company Matches] RSS

06:06 EST 20th February 2019 | BioPortfolio

Here are the most relevant search results for "Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer" found in our extensive corporate database of over 50,000 company records.

Showing "Radiation Therapy Combination Chemotherapy Treating Patients With Stage" Companies 1–25 of 6,000+

Extremely Relevant

Genetronics Biomedical

Genetronics' most advanced effort involves treating those with head and neck cancer, a particularly devastating cancer that can severely limit the ability of these patients to see, taste, hear, talk, breathe, or swallow. Genetronics received approval from the U.S. Food and Drug Administration and initiated Phase II multi-center clinical trials at nine sites in the U.S. The trials test the effectiv...


Radiation Therapy Services, Inc.

Radiation Therapy Services, Inc. is a leading developer and operator of radiation therapy centers. These centers, which are freestanding and hospital based, provide a full spectrum of radiation therapy services to cancer patients, including conventional external beam radiation treatments as well as advanced services such as prostate seed implants (brachyth...

Cancer Therapeutics, Inc.TM

Founded in 1991, Cancer Therapeutics, Inc.TM (CTI) is a biotherapy company that is a leader in activated cell technology for cancer therapy. CTI's laboratory offers access to technologies grouped under the modality of Biotherapy. Biotherapy is based on treatments that enhance the patient's own immune system to attack the invading cancer. Research has shown cancer to be a highly individualized dise...


Relevant

CDH Proton Center

CDH Proton Center, A ProCure Center, Warrenville, Ill., is one of a handful of facilities in the country that offer proton therapy, an advanced form of radiation to treat cancer. The four-room, 60,000 sq. ft. Center, opened Oct. 19, 2010, is the first for Illinois and has the capacity to treat up to 1,500 patients a year. The precision of proton therapy sp...

Bellingham Regional Breast Center

The Bellingham Regional Breast Center provides comprehensive diagnosis and treatment for all breast disorders. Services include early diagnosis; risk analysis with genetic counseling and testing; treatment with surgery, radiation therapy, chemotherapy, endocrine therapy, targeted therapies, and immune therapy; and supportive care including counseling, phys...

Oncolytics Biotech Inc.

Oncolytics Biotech Inc. was formed in 1998 to develop its proprietary product, REOLYSIN®, as a potential therapeutic for a wide variety of human cancers. Oncolytics has completed five clinical trials with REOLYSIN® in Canada and the U.K. and is currently conducting four Phase I or Phase I/II REOLYSIN® trials in the U.K. and the U.S. The company also has permission to commence a Phase II combina...

ViewRay Incorporated

ViewRay Incorporated is developing an advanced system to treat cancer patients: the world's first real-time MRI guided radiation therapy device. The Renaissance(TM) System technology will continuously image the patient in three dimensions during radiation therapy delivery. This real time imaging will control the delivery of the radiation therapy and record the dose delivered to the patient, allowi...

EUSA Pharma Inc

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high dose chemotherapy, Erwinas...

Parnell Pharmaceuticals

Parnell Pharmaceuticals is the first company dedicated to the research and development of new and innovative products to restore and maintain mucosal integrity, thereby improving the quality of life of those patients, who for diverse reasons are "mucocompromised", and therefore at increased risk for secondary infections. The majority of these patients are defined as immunocompromised for various r...

OncoWell, LLC

OncoWell, LLC, headquartered in New York, NY, provides complementary products and resources to patients undergoing cancer treatment. The company’s first offering, OncoWellCE, is a concentrated enzyme product to support patient wellness while undergoing chemotherapy or radiation therapy. OncoWell, LLC was founded in 2012 by James Nicholls, Peter Jenkin...

EUSA Pharma

EUSA Pharma is a rapidly growing transatlantic specialty pharmaceutical company focused on in-licensing, developing and marketing late-stage oncology, pain control and critical care products. The company currently has eight marketed products, including Caphosol(R) for the treatment of oral mucositis, a common and debilitating side-effect of radiation therapy and high dose chemotherapy, Erwinas...

US Oncology Network

Optim Oncology is dedicated to providing patient-centered, integrated cancer care in convenient locations close to patients’ homes. Medical and radiation specialists work together in one location to facilitate fully coordinated comprehensive team care, providing the potential for better outcomes and reducing patients’ stress by eliminating the need to ...

Alliance Oncology

Alliance Oncology partners with hospitals and radiation oncologists to set a new standard of care for cancer patients. This is achieved through the establishment of state-of-the-art cancer centers or the enhancement of existing facilities with advanced technologies, including Intensity Modulated Radiation Therapy (IMRT), Image Guided Radiation Therapy (IGR...

North American Scientific

Our Mission To pursue with passion the development and introduction of innovative new products that empower physicians and patients with individualized, life-saving treatment solutions. Company Overview Little more than ten years ago, radiation oncology was as much a source of frustration as of hope for its dedicated professionals. Physicians had to face the fact that they often did more harm...

GammaCan

GammaCan is a biopharmaceutical company focused on clinical-phase development and commercialization. GammaCan’s initial therapy under development is a first-in-class anti-cancer immunotherapy aimed at preventing metastasis (the spread of cancer to other parts of the body) of a variety of cancers. GammaCan’s first product was entered to phase-II clinical trials.GammaCan’s innovative treatment...

IntraOp Medical Corporation

IntraOp Medical Corporation provides innovative technology solutions for the treatment and eradication of cancer. Founded in 1993, IntraOp is committed to providing the tools doctors need to administer intra-operative radiation therapy safely and effectively – for all cancer patients. The company’s flagship product, Mobetron, is the first fully p...

Cancer Supportive Care Programs

The mission of the Cancer Supportive Care Web Site (CSCW) is to provide multidisciplinary information and services for cancer patients and their families/friends This website provides online support for patients undergoing surgery, radiation therapy, chemotherapy, hormonal therapy or immunotherapy. El Cuidado Sustento Del Cáncer de Ernest H. Rosenbaum, MD y Isadora R. Rosenbaum, MA La Declaració...

SightLine Health

SightLine Health, headquartered in Houston, Texas, specializes in groundbreaking cancer treatments such as intensity-modulated radiation therapy (IMRT), image-guided radiation therapy (IGRT), high-dose-rate (HDR) brachytherapy, and electron-beam radiation therapy. The company opened its first facility, near the renowned Texas Medical Center, in 2005. Today...

Kepivance™ (palifermin)

Kepivance™ (palifermin) is indicated to decrease the incidence and duration of severe oral mucositis (mouth sores) in patients withhematologic (blood) cancers undergoing high-dose chemotherapy, with or without radiation, followed by bone marrow transplant. The safety and efficacy of Kepivance™ have not been established in patients with nonhematologic malignancies.

ProCertus BioPharm, Inc.

ProCertus BioPharm is an oncology-based pharmaceutical company whose primary mission is to protect cancer patients against the side effects of chemotherapy and radiotherapy.ProCertus has established proof of concept in animal models for its product candidates, DermX, ProDermaCel™, and OralX, proprietary pharmaceuticals designed to reduce or eliminate the side effects associated with cancer thera...

Emmerex

Emmerex is an early stage bio-pharmaceutical company. It aims to bring to market an anti-cancer therapy. The Emmerex therapy arose as a result of several years' biological research. It has already been proven to be safe in patients. The Emmerex therapy utilises the patients' own innate ability to fight cancer. It cuts off nutrient source of the cancer and attacks the tumours directly. The Emmerex ...

Coalition for Pulmonary Fibrosis

Pulmonary Fibrosis (PF) is a lung disorder characterized by a progressive scarring - known as fibrosis -- and deterioration of the lungs, which slowly robs its victims of their ability to breathe. Approximately 128,000 Americans suffer from PF, and there is currently no known cause or cure. An estimated 48,000 new cases are diagnosed each year. PF is difficult to diagnose and an estimated two-thir...

Xstrahl

Xstrahl is a leading designer and manufacturer of X-ray systems for use in cancer and dermatology treatments and radiation biology research, providing complete solutions for all X-ray therapy and research applications. Xstrahl has more than 15 years’ experience supporting the X-ray therapy requirements of healthcare providers around the world, from in...

Sonrgy, Inc.

Sonrgy is a preclinical stage biotechnology company based in San Diego, California that is developing a targeted chemotherapy delivery platform to improve survival and quality of life for millions of cancer patients. Sonrgy’s tiny nanocarriers safely transport potent chemotherapy drugs to cancer tumors and release high doses on command in response to a focus...

Xoft Inc.

Xoft, founded in 1998, develops Electronic Brachytherapy (eBx) systems based upon miniaturized X-ray tube technology for the practice of radiation oncology in virtually any clinical setting, eliminating the need for heavily shielded environments. Xoft provides a "point of care model" that is patient centric and accessible to a broader spectrum of patients and their physicians. The Axxent treat...


More From BioPortfolio on "Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II or Stage III Bladder Cancer"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks